SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell cycle inhibitors to guide tissue formation

SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell cycle inhibitors to guide tissue formation

Tissue formation and organ homeostasis are achieved by precise coordination of proliferation and differentiation of stem cells and progenitors. While deregulation of these processes can result in degenerative disease or cancer, their molecular interplays remain unclear. Here we show that the switch...

Descripció completa

Dades bibliogràfiques
Autors principals:	Militi, S, Nibhani, R, Pook, M, Pauklin, S
Format:	Journal article
Idioma:	English
Publicat:	Oxford University Press 2024

Ítems similars

RBL2-E2F-GCN5 guide cell fate decisions during tissue specification by regulating cell-cycle-dependent fluctuations of non-cell-autonomous signaling
per: Militi, S, et al.
Publicat: (2023)

RBL2-E2F-GCN5 guide cell fate decisions during tissue specification by regulating cell-cycle-dependent fluctuations of non-cell-autonomous signaling
per: Stefania Militi, et al.
Publicat: (2023-09-01)

Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
per: Kwangho Kim, et al.
Publicat: (2023-05-01)

BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma
per: Feng, Y, et al.
Publicat: (2023)

SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
per: Shanshan Wang, et al.
Publicat: (2023-07-01)

KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics
per: Mouti, MA, et al.
Publicat: (2023)

Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
per: Michael J Thomenius, et al.
Publicat: (2018-01-01)

Epigenetic and transcriptional regulations prime cell fate before division during human pluripotent stem cell differentiation
per: Madrigal, P, et al.
Publicat: (2023)

ZNF8 Orchestrates with Smad3 to Promote Lung Metastasis by Recruiting SMYD3 in Breast Cancer
per: Wenwen Geng, et al.
Publicat: (2024-10-01)

Emerging epigenetic therapies: protein arginine methyltransferase inhibitors
per: Pook, H, et al.
Publicat: (2023)

SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells
per: Bradley J. Toghill, et al.
Publicat: (2018-03-01)

KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics
per: Mai Abdel Mouti, et al.
Publicat: (2023-09-01)

Characterizing the Role of SMYD2 in Mammalian Embryogenesis—Future Directions
per: Dillon K. Jarrell, et al.
Publicat: (2020-05-01)

Cardiac deletion of Smyd2 is dispensable for mouse heart development.
per: Florian Diehl, et al.
Publicat: (2010-03-01)

Epigenetic and transcriptional regulations prime cell fate before division during human pluripotent stem cell differentiation
per: Pedro Madrigal, et al.
Publicat: (2023-01-01)

The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms
per: Chang, C-H, et al.
Publicat: (2024)

TGFB1/INHBA homodimer/nodal-SMAD2/3 signaling network: a pivotal molecular target in PDAC treatment
per: Abdel Mouti, M, et al.
Publicat: (2021)

Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis
per: Yi Zeng, et al.
Publicat: (2019-11-01)

Synergistic anticancer effects of SMYD2 inhibitor BAY-598 and doxorubicin in non-small cell lung cancer
per: Jiaqi Meng, et al.
Publicat: (2024-06-01)

Anticancer Impact of Nitric Oxide (NO) and NO Combination with SMYD-3 Inhibitor on Breast Carcinomas
per: Jenna L. Gordon, et al.
Publicat: (2021-11-01)

Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN
per: Makoto Nakakido, et al.
Publicat: (2015-04-01)

The lysine methyltransferase SMYD5 amplifies HIV-1 transcription and is post-transcriptionally upregulated by Tat and USP11
per: Daniela Boehm, et al.
Publicat: (2023-03-01)

Structural Analysis of SMYD3 Lysine Methyltransferase for the Development of Competitive and Specific Enzyme Inhibitors
per: Dillon K. Jarrell, et al.
Publicat: (2021-12-01)

A Drosophila Smyd4 homologue is a muscle-specific transcriptional modulator involved in development.
per: Elizabeth C Thompson, et al.
Publicat: (2008-08-01)

Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis
per: Alexandre G. Casanova, et al.
Publicat: (2024-01-01)

Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke
per: Jinghuan Wang, et al.
Publicat: (2022-03-01)

SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7
per: Lei Wu, et al.
Publicat: (2021-05-01)

SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells
per: Yang Yang, et al.
Publicat: (2022-12-01)

The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms
per: Chao-Hui Chang, et al.
Publicat: (2024-04-01)

Advances of Histone Methyltransferase SMYD3 in Tumors
per: Shangwen DONG, et al.
Publicat: (2014-09-01)

Host factor SMYD3 is recruited by Ebola virus nucleoprotein to facilitate viral mRNA transcription
per: Jingliang Chen, et al.
Publicat: (2019-01-01)

Pharmacological inhibition of SMYD2 protects against cisplatin-induced renal fibrosis and inflammation
per: Min Chen, et al.
Publicat: (2023-09-01)

Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation
per: Haibi Su, et al.
Publicat: (2022-10-01)

SMYD2 aggravates gastrointestinal stromal tumor via upregulation of EZH2 and downregulation of TET1
per: Yong Ji, et al.
Publicat: (2022-06-01)

SMYD3 drives cell cycle and epithelial-mesenchymal transition pathways through dual gene transcriptional repression and activation in HPV-negative head and neck cancer
per: Madhavi Murali, et al.
Publicat: (2025-01-01)

Evolutionary History of the Smyd Gene Family in Metazoans: A Framework to Identify the Orthologs of Human Smyd Genes in Drosophila and Other Animal Species.
per: Eduardo Calpena, et al.
Publicat: (2015-01-01)

Initiation of stem cell differentiation involves cell cycle-dependent regulation of developmental genes by Cyclin D
per: Pauklin, S, et al.
Publicat: (2016)

SMYD proteins in immunity: dawning of a new era
per: Maysaa Doughan, et al.
Publicat: (2016-10-01)

SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis.
per: Xiangli Ye, et al.
Publicat: (2016-01-01)

Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis
per: Alexandre G. Casanova, et al.
Publicat: (2024-03-01)